Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: In Vitro Evidence
Mirko Manetti(University of Florence), Marco Matucci‐Cerinic(Azienda Ospedaliero-Universitaria Careggi)
Cited by 19
Related Papers
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
|Annals of the Rheumatic Diseases|2009|615
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
|Scientific Reports|2017|48
Telocytes in normal and keratoconic human cornea: an immunohistochemical and transmission electron microscopy study
|Journal of Cellular and Molecular Medicine|2017|47
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells
|Arthritis Research & Therapy|2017|32
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome
|Journal of Cellular and Molecular Medicine|2016|30